N6,N6-Dimethyladenosine (Standard)

Overview

N6,N6-Dimethyladenosine (Standard) is the analytical standard of N6,N6-Dimethyladenosine ( HY-101984 ). This product is intended for research and analytical applications. N6,N6-Dimethyladenosine , a modified ribonucleoside, is an endogenous A3 adenosine receptor ligand. N6,N6-Dimethyladenosine is an AKT inhibitor with antitumor effects. N6, N6-Dimethyladenosine targets SARS-CoV-2 entry protein ADAM17 . N6, N6-Dimethyladenosine robustly inhibits AKT signaling in a variety of non-small cell lung cancer cell lines.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Akt | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Nucleoside Antimetabolite/Analog | Products > Signaling Pathways > Adenosine Receptor

Product Information

• Catalog No.: HY-101984R
• CAS No.: 2620-62-4
• Molecular Formula: C12H17N5O4
• Molecular Weight: 295.29
• Purity: 99.94%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source